Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.9866
-0.0734 (-6.92%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Moleculin Biotech Employees
Moleculin Biotech had 17 employees as of December 31, 2024. The number of employees decreased by 1 or -5.56% compared to the previous year.
Employees
17
Change (1Y)
-1
Growth (1Y)
-5.56%
Revenue / Employee
n/a
Profits / Employee
-$1,280,176
Market Cap
13.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
MBRX News
- 11 days ago - Moleculin Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 - GlobeNewsWire
- 27 days ago - Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial - GlobeNewsWire
- 5 weeks ago - Moleculin Biotech, Inc. (MBRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Moleculin Reports Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Moleculin to Report Full Year 2024 Financial Results on March 21, 2025 and Host Conference Call and Webcast - GlobeNewsWire
- 6 weeks ago - Moleculin Biotech, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference - PRNewsWire
- 7 weeks ago - Moleculin to Present at the 37th Annual ROTH Conference - PRNewsWire
- 7 weeks ago - Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity - PRNewsWire